| (S)-Trichostatin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (2R,4R,6S)-Tubacin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (E,E)-RGFP966 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| (E/Z)-Dacinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-Dihydrolipoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-HDAC-IN-102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Nanatinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-HDAC-IN-102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-TNG260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.39% |
| 1-Alaninechlamydocin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1-Naphthohydroxamic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| 1-Stearoyl-sn-glycero-3-phosphocholine-d35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99% |
| 1-Stearoyl-sn-glycero-3-phosphocholine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| 2-Hexyl-4-pentynoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| 2-Propylpent-4-ynoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Iodo-SAHA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.12% |
| 4-Phenylcinnamic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Phenylbutyric acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| 4-Phenylbutyric acid-d11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| 4-Phenylbutyric acid-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| 4-Phenylbutyric acid-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5-Bromo-2,3-dihydro-1H-inden-1-one |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Valproic acid-d7 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 9-Hydroxyoctadecanoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| A2AAR/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| A2AAR/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AAK1/HDACs-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Abexinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.00% |
| AC-340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ac-Arg-Gly-Lys(Ac)-AMC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Ac-Lys-AMC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Ac-QPKK(Ac)-AMC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ac-QPKK(Ac)-AMC acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.38% |
| AChE/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ACY-1083 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| ACY-738 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| ACY-775 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| ACY-957 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| AES-135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.68% |
| AES-350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| ALK/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ALK/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Alteminostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.66% |
| AMC-3-030 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| anti-TNBC agent-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Apicidin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.49% |
| Apicidin C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AR-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.52% |
| AR420626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.40% |
| Aurora kinase/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AW01178 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Azumamide E |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BATCP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Bavarostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| BChE/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BChE/HDAC6-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BG14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BG45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| BG47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BG48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.09% |
| BML-210 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| Boc-Lys(Ac)-AMC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.59% |
| Bocodepsin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.01% |
| Bocodepsin hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BPKDi |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| BRD 4354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| BRD 4354 ditrifluoroacetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD-6929 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.01% |
| BRD2492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| BRD3308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.34% |
| BRD4097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD4884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| BRD6688 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.06% |
| BRD73954 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.13% |
| BRD9757 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Butyrylhydroxamic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| c-Met/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| c-Met/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| c-Met/HDAC-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C1A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CA/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CARM1/HDAC2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.17% |
| CAY10603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| CDK/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDK/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| CDK/HDAC-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDK4/6/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDK9/HDAC1/HDAC3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CG-1521 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.71% |
| CG347B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| CHDI-00484077 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.38% |
| CHDI-390576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| Chlamydocin (purity≥70%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chlopynostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.36% |
| cis-BG47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Citarinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| CLK1/4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CM-1758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| CM-414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CM-444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CM-545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CM-675 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| Corin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.16% |
| Coumarin-SAHA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| COX-2/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CRA-026440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CRA-026440 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.12% |
| Crebinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.83% |
| Croconic acid disodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| CS4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CUDC-101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| Curcuphenol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYD19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| CYP17A1/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CYP51/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Daphnegiravone D |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DD0-2363 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diheteropeptin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dihydrochlamydocin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dihydrochlamydocin analog-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DKFZ-748 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.98% |
| DL-Sulforaphane N-acetyl-L-cysteine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| DLC-50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DNA-PK/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DNMT/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| DNMT/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DNMT1/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Domatinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| Domatinostat tosylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| Droxinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| DS-103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EGFR/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EGFR/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Elevenostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.07% |
| Estrogen receptor β/HDAC probe 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| F-SAHA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| F2F-202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FF2039 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FF2049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FFK29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fibrostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fimepinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Fimepinostat mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FITC-SAHA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FLT3/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FLT3/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FLT3/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FLT3/VEGFR2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FNDR-20123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| FNDR-20123 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FT108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FT234 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FT895 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| G194-0712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| G4/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GEM144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Givinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.67% |
| Givinostat hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.06% |
| Givinostat hydrochloride monohydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| GK444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GK718 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gnetol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| GRK2 modulator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK-3β/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK-3β/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GSK3117391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| GV-001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H8-A5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HC-Toxin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.26% |
| HD-TAC7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.53% |
| HDAC degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-101 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.12% |
| HDAC-IN-27 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| HDAC-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| HDAC-IN-40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.71% |
| HDAC-IN-41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| HDAC-IN-53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.73% |
| HDAC-IN-54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-61 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-62 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-66 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-68 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-69 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.15% |
| HDAC-IN-71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-73 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-74 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-76 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-79 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-81 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-82 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-83 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-84 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-87 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| HDAC-IN-88 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-89 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-90 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-91 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-92 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-93 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-94 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-95 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-96 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-98 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.36% |
| HDAC-IN-99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/BET-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/CD13-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/CK2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/HSP90-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/JAK/BRD4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/NAMPT-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/PSMD14-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC/Top-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1 activator-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac1 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac1 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| HDAC1-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1/2 and CDK2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1/2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| HDAC1/3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| HDAC1/6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1/6-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1/6-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1/CDK7-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC1/MAO-B-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC10 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac10 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac10 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC10-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.33% |
| HDAC10-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC10-IN-2 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| HDAC10-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC10-IN-3 formic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC11 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac11 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC11-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC11-IN-1 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.25% |
| HDAC11-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| HDAC11-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| HDAC11-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| HDAC11-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC2 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac2 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| HDAC2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3 degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac3 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac3 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| HDAC3-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3-IN-T247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.35% |
| HDAC3/6-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3/8 ligand-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC3/BRD4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC4 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC4 ligand-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac4 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac4 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| HDAC5 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| HDAC6 degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.12% |
| HDAC6 degrader-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6 degrader-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| HDAC6 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6 ligand-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.70% |
| HDAC6 ligand-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6 ligand-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6 ligand-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6 ligand-Linker Conjugate 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6 ligand-Linker Conjugate 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac6 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.08% |
| HDAC6-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| HDAC6-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| HDAC6-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| HDAC6-IN-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| HDAC6-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.96% |
| HDAC6-IN-34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.51% |
| HDAC6-IN-47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-58 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-59 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-61 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-62 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-63 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-66 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-69 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-70 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-73 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-74 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| HDAC6-IN-76 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-77 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-79 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-81 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-82 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-83 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6/8/BRPF1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6/HSP90-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6/HSP90-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC6/HSP90-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC7 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac7 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8 ligand 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac8 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| HDAC8-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC8-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| HDAC8/BRPF1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC9 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hdac9 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC9-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.13% |
| HDACs/EZH2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDACs/mTOR Inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| HDSI-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HFY-4A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| HIT211504993 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HL23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| HNHA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Homobutein |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.35% |
| HPB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| HPO-DAEE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HPOB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| HR488B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hsp110/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HYF031 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IDO1 and HDAC1 Inhibitor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IHCH-3064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IHCH-3185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Imofinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| IMPDH II/HDAC1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IOR-160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ITF 3756 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.55% |
| ITF5924 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ITSA-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.73% |
| Ivaltinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Ivaltinostat formic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| J1038 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J1075 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J22352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.04% |
| J27644 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JAK/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.63% |
| JAK/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JAK/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JAK/HDAC-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JMJD3/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JNJ-16241199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| JPS004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JPS014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JPS014 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.12% |
| JPS016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JPS016 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| JPS035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JPS036 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| KA2507 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.17% |
| KA2507 monohydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KBH-A42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KD 5170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.13% |
| KH-259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KH16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.62% |
| KPZ560 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| KR-39038 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| KT-531 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KT32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KTT-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Largazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Largazole thiol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LASSBio-1911 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LB-205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Leuxinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LMK-235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.25% |
| LSD1/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LSD1/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LSD1/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LSD1/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LSD1/HDAC6-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| LSQ-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LT-630 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LTK-14A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LW479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| m-Carboxycinnamic acid bishydroxamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| M122 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| M133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| M344 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| M344 (GMP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mad1 (6-21) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Mad1 (6-21) TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MAO A/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Martinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Martinostat hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.01% |
| MC1568 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.08% |
| MC1742 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.95% |
| MC2590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.71% |
| MC2625 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MC4343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MD 85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| MFDCH016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MHY219 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MI-192 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| MIR002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Mocetinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.13% |
| MOCPAC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| MPI_5a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| MPT0B390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.76% |
| MPT0G211 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| MPT0G211 mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MPT0G413 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MRLB-223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| mTOR/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| mTOR/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mz325 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| Nampt-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.97% |
| Nanatinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| Nanatinostat TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Naph-Se-TMZ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NB512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NCC-149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.65% |
| NCT-10b |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NCT-14b |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nexturastat A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.69% |
| NHNB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NI-Pano |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NKL 22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.26% |
| NL-103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NMDAR/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NN-390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NN-429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NR160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NSC3852 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| NT160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| NT376 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nullscript |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.18% |
| OKI-005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| OKI-006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Oleuropein Aglycone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.46% |
| Oxamflatin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.10% |
| Panobinostat lactate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.67% |
| PARP-1/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7/HDACs-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PB118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PB131 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| PB200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PB94 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| PCI-34051 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| PD-L1/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PD-L1/HDAC3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PD-L1/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PD-L1/HDAC6-IN-1 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| PDE5/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PH14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| PHD2/HDACs-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3K/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3K/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3K/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3K/HDAC-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3Kα/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PI3Kδ/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PIM-1/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PIM-1/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pimelic Diphenylamide 106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.54% |
| Pimelic Diphenylamide 106 analog |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.06% |
| Pinocembrin 7-O-[3''-O-galloyl-4'',6''-hexahydroxydiphenoyl]-β-D-glucoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.92% |
| Pivanex |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| POI ligand 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PPM-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.17% |
| Pracinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Pracinostat dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PRO-HD1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PRO-HD2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PRO-HD3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC degrader-2 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.68% |
| PROTAC HDAC3 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC4 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC4 Degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC6 degrader 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC6 degrader 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| PROTAC HDAC6 degrader 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| PROTAC HDAC6 degrader 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC6 degrader 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC6 degrader 6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC6 degrader 7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC6 degrader 8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC6 degrader 9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC8 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC8 Degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC8 Degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC HDAC8 Degrader-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Psammaplin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.0% |
| PT3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| PTACH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.04% |
| PTER-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| PTG-0861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| Purinostat mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Pyroxamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| PySAHA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| QTX125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| QTX125 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Quisinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| Quisinostat dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| Quisinostat hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remetinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Resminostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| Resminostat hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| RG2833 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| RGFP966 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Ricolinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| ROCK/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ROCK/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rodin-A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rodin-B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rodin-C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Romidepsin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RSC133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.45% |
| RTS-V5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S234984 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| SAHA-OH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Santacruzamate A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| SAP15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SAP15 acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| SB-429201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.15% |
| Scriptaid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.09% |
| SE-7552 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.35% |
| sEH/HDAC6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| sEH/HDAC6-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SelSA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| SeSA-HCPT |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SGC-UBD253 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.3% |
| SHP2/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SIRT6-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.19% |
| SIS17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| SJY26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SK-7041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SKLB-23bb |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| SM-06-09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sodium butyrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SP-2-225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SR-4370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.38% |
| SS-208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.00% |
| ST13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ST17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ST7612AA1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ST8155AA1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| STAT3/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| STR-V-53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Suberoyl bis-hydroxamic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| SW-100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| SZUH280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.38% |
| T-518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.40% |
| T326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tasquinimod-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.34% |
| TD034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Tefinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Temozolomide-amino hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TH-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.00% |
| TH34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Theophylline L-lysine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tinostamustine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| Tinostamustine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TMP195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| TMP269 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.16% |
| TMU 35435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNG260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| TNI-97 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TO-1187 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TO-1187 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.41% |
| Top/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Top/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Top/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Topo II/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Topo II/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trichostatin C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Triciferol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.61% |
| Tubacin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97.11% |
| Tubastatin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tubastatin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| Tubastatin A Hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| Tubastatin A TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tubulin/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tubulin/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tubulin/HDAC-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tubulin/HDAC-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TW9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TYA-018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| UBD1031 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UF010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| Valproic acid (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Valproic acid sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valproic acid sodium (2:1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valproic acid β-D-glucuronide-d15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valproic acid β-D-glucuronide-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VEGFR2/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VEGFR2/HDAC1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vorinostat (GMP) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vorinostat-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| VUBI1 analogue-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| W2A-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Wee1/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| WJ35435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| WMJ-J-09 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| WT-161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| WW437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XP5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XSJ-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95.16% |
| YF438 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YF479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YKL-05-093 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YM1240 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YPX-C-05 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| YSR734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.20% |
| YX862 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YX968 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.06% |
| Z-MAL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Zabadinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| ZG-126 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZINC000028464438 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZMF-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZSNI-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZWZH-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZYJ-25e |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZYJ-34c |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZYJ-34v |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bufexamac |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.47% |
| Butyric acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Butyric acid-13C-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Butyric acid-13C2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Butyric acid-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.14% |
| Sodium butyrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Sodium butyrate-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Sodium butyrate-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valproic acid-d15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Valproic acid-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Valproic acid-d4 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valproic acid-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Valproic acid-d4-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.5% |
| Valproic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Valproic acid β-D-glucuronide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valproic acid-d14 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96.73% |
| Valproic acid sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Valproic acid magnesium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tacedinaline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.32% |
| Theophylline sodium acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tasquinimod |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Vorinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Carbamazepine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Deoxyandrographolide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Nicoxamat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| Panobinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.37% |
| Panobinostat-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Panobinostat-d4 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Entinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Entinostat-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90.31% |
| Splitomicin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.34% |
| Trichostatin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Pomiferin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.01% |
| Manganese chloride tetrahydrate, molecular biology grade,≥99.0% (KT) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| Crotonoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| Andrographidine E |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Romidepsin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Romidepsin-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sinapinic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| 5-Phenylpentan-2-one |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Sodium 4-phenylbutyrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Phenylbutyrate-d11 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Theophylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Theophylline-13C2,d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Theophylline-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Theophylline monohydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Theophylline (sodium glycinate) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sulforaphane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.01% |
| Bakkenolide A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Tucidinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.74% |
| Tucidinostat-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.63% |
| Belinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Belinostat-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dacinostat |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
98.45% |
| Marein |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Rhamnetin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
99.18% |